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We screened Salmonella and Escherichia coli isolates, 
collected 2004–2008 in the United Kingdom, for 16S rRNA 
methyltransferases. rmtC was identiﬁ  ed in S. enterica se-
rovar Virchow isolates from clinical samples and food. All 
isolates were clonally related and bore the rmtC gene on 
the bacterial chromosome. Surveillance for and research on 
these resistance determinants are essential. 
A
minoglycosides are used in treating a wide range of 
infections caused by both gram-negative and gram-
positive bacteria and have been classiﬁ  ed by the World 
Health Organization as critically important antimicrobial 
drugs in human medicine (1). They inhibit bacterial pro-
tein synthesis by binding irreversibly to the bacterial 16S 
ribosomal subunit, which thereby leads to cell death. Re-
sistance to these antimicrobial agents usually results from 
production of aminoglycoside-modifying enzymes (such as 
acetyltransferases, phosphorylases, and adenyltransferas-
es), reduced intracellular antimicrobial drug accumulation, 
or mutation of ribosomal proteins or rRNA. An addition-
al mechanism, methylation of the aminoacyl site of 16S 
rRNA, confers high-level resistance to clinically important 
aminoglycosides such as amikacin, tobramycin, and gen-
tamicin. Six types of 16S rRNA methyltransferase genes 
conferring resistance to these antimicrobial agents, armA, 
rmtA, rmtB, rmtC, rmtD, and npmA, have been identiﬁ  ed 
(2,3). armA and rmtB are spread in enterobacteria world-
wide, and the presence of other methyltransferase genes 
have not previously been reported in Europe (3). With the 
exceptions of armA and rmtB in porcine Escherichia coli 
from Spain and the People’s Republic of China, respective-
ly (4,5), all methyltransferase genes described have been 
identiﬁ  ed in human clinical samples, for which a possible 
role for food in transmission of these determinants remains 
largely unknown. Despite large surveys performed to iden-
tify 16S rRNA methyltransferases, the rmtC gene has been 
detected in only 2 Proteus mirabilis clinical isolates from 
Japan and Australia in 2006 and 2008, respectively (3,6,7). 
In this study, 81,632 Salmonella and 10,700 Escherichia 
coli isolates obtained from the Health Protection Agency 
(HPA) Centre for Infections culture collection (isolated 
from January 2004 through December 2008) were screened 
for the presence of 16S rRNA methyltransferases.
The Study
 Salmonella enterica (56 isolates) and Escherichia coli 
(24 isolates) were selected from the HPA collection based on 
their resistance to amikacin (breakpoint concentration rou-
tinely used in HPA Salmonella Reference Unit = 4 μg/mL). 
Because 16S rRNA methyltransferases confer high-level re-
sistance to amikacin, 13 S. enterica isolates were selected on 
the basis of ability to grow on Isosensitest agar containing 
500 μg/mL amikacin, whereas none of the E. coli isolates 
grew under these conditions. All isolates belonged to sero-
type Virchow. Further antimicrobial susceptibility testing by 
microdilution by using dehydrated Sensititer plates following 
the CLSI guidelines conﬁ  rmed high-level resistance to 4,6-
disubstituted 2-deoxystreptamines (Table 1). PCR screening 
of the 13 isolates for armA, rmtA, rmtB, rmtC, and rmtD (8) 
identiﬁ  ed  rmtC. Nucleotide sequencing of the amplicons 
conﬁ  rmed an rmtC gene with 100% identity with those origi-
nally identiﬁ  ed in Proteus mirabilis strain ARS68 isolated 
from an inpatient in Japan (6) and P. mirabilis strain JIE273 
from Australia (7). To our knowledge, this is the third report 
of rmtC-bearing bacteria. Class one integrons were ampli-
ﬁ  ed (9), and sequenced. Isolates resistant to neomycin bore 
the aac(6′)-Ib gene cassette, whereas the dfrA1 gene was re-
sponsible for resistance to trimethoprim.
Twelve of the 13 S. enterica strains were originally 
isolated over a 4-year period from patients with clinical in-
fection; 1 strain was obtained from frozen produce. Seven 
of 12 strains were obtained from patients with histories of 
foreign travel; 4 of the 7 patients had reported recent travel 
to India (Table 2). P. mirabilis strain JIE273 was also iso-
lated from a patient who had recently returned from India 
(7). Investigations to ascertain the presence of rmtC genes 
in India are under way. To identify a possible link between 
the isolates, chromosomal DNA was embedded in agarose 
plugs prepared according to the pulsed-ﬁ  eld gel electro-
phoresis (PFGE) protocol of PulseNet Europe (10). PFGE 
patterns showed only 1–2-band differences (Figure 1) and 
correlated with phage typing data (Table 1). All clinical 
isolates were recovered from feces, except a blood iso-
late recovered from a patient with invasive salmonellosis 
(Table 2). The temporal and geographic distribution of the 
isolates suggested independent acquisition of infections in 
most cases and possibly epidemiologically linked cases, 
e.g., strains 9 and 10 (Table 2; Figure 2).
DISPATCHES
712  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 4, April 2010
Author afﬁ  liations: Health Protection Agency Centre for Infections, 
London, UK (K.L. Hopkins); and Universidad Complutense de Ma-
drid, Madrid, Spain (J.A. Escudero, L. Hidalgo, B. Gonzalez-Zorn)
DOI: 10.3201/eid1604.090736S. enterica ser. Virchow with rmtC
PCR with primers ISEcp1R-F and rmtC-down (7) 
showed that the rmtC gene and immediate upstream se-
quences (GenBank accession nos. FJ984623–FJ984634 
for human isolates and GQ131574 for the food isolate) 
were identical to those previously identiﬁ  ed in P. mirabi-
lis (6,7), in which ISEcp1 has been shown to play a role 
in the expression and transposition of the rmtC gene (11). 
However, the complete ISEcp1 element could not be am-
pliﬁ  ed by using primers ISEcp1 5′ and ISEcp1 reverse, 
which suggests either partial deletion of this element or 
involvement of a different ISEcp1-like element in spread 
of rmtC in Salmonella (6,12). Attempts to isolate rmtC 
by conjugal transfer to rifampin-resistant E. coli 20R764 
were unsuccessful, as was electroporation into E. coli 
LMG194 and ElectroMAX DH10B cells (both Invitrogen, 
Paisley, UK) by using plasmid preparations. An ≈100-kb 
rmtC-bearing plasmid was previously transferred from 
P. mirabilis ARS68 by electroporation but could not be 
mobilized by conjugation (6), and attempts to transfer 
the rmtC plasmid from P. mirabilis JIE273 by electropo-
ration and conjugation failed (7). This ﬁ  nding contrasts 
with some qualities of the other methyltransferases, such 
as armA and rmtB, which are mostly located on conjuga-
tive plasmids (8,13). 
The location of the rmtC gene was determined with 
PFGE by using I-CeuI nuclease treatment. Agarose plugs 
were digested with 9.5 U I-CeuI nuclease (New England 
Biolabs, Beverly, MA, USA). Separated DNA fragments 
were transferred onto a nylon membrane (GE Healthcare, 
Madrid, Spain) and hybridized with 16S rDNA and rmtC 
probes labeled with DIG-11-dUTP. Hybridization, label-
ing, and detection were performed according to the man-
ufacturer’s recommendations (Roche Applied Science, 
Mannheim, Germany). A DNA band hybridized with both 
probes, showing that the rmtC gene was located on the chro-
mosome. Results of hybridization of plasmid extractions 
(Plasmid Midi kit; QIAGEN, Inc., Chatworth, CA, USA) 
with the rmtC probe were negative (data not shown).
Conclusions
We describe the occurrence of 16S rRNA methyltrans-
ferase rmtC in Salmonella isolates and the rmtC gene in 
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Table 1. Phage types for Salmonella enterica serovar Virchow isolates bearing rmtC and MICs of selected antimicrobial agents* 
Isolate
Phage
type GEN KAN AMK TOB ARB NEO TMP CPX AMP
HO 5164 0340 ND >512 >512 >512 >512 >512 64 <0.5 0.5 1
HO 5366 0426 30 >512 >512 >512 >512 >512 2 >32 0.25 <0.05
HO 6018 0151 30 >512 >512 >512 >512 >512 2 >32 0.25 1
HO 6316 0322 30 >512 >512 >512 >512 >512 32 <0.5 0.25 1
HO 6398 0463 30 >512 >512 >512 >512 >512 32 <0.5 0.25 1
HO 7078 0136 30 >512 >512 >512 >512 >512 2 >32 0.25 <0.05
HO 7310 0210 31 >512 >512 >512 >512 >512 4 >32 0.25 1
HO 7468 0335 25 >512 >512 >512 >512 >512 2 >32 0.5 1
HO 7474 0467 25 >512 >512 >512 >512 >512 4 >32 0.25 <0.05
HO 7496 0137 25 >512 >512 >512 >512 >512 2 >32 0.25 1
HO 7512 0259 25 >512 >512 >512 >512 >512 4 >32 0.25 1
HO 8354 0857 25 >512 >512 >512 >512 >512 4 >32 0.25 <0.05
HO 8512 0713 25 >512 >512 >512 >512 >512 4 >32 0.25 1
*MICs are given in μg/mL. GEN, gentamicin; KAN, kanamycin; AMK, amikacin; TOB, tobramycin; ARB, arbekacin; NEO, neomycin; TMP, trimethoprim; 
CPX, ciprofloxacin; AMP, ampicillin; ND, not determined. 
Table 2. Epidemiologic information from rmtC-positive Salmonella enterica serovar Virchow isolates, United Kingdom, 2004–2008* 
Isolate Date received Map no. Location Sample type Symptoms Travel history
HO 5164 0340 2005 Apr 20 1 Reading Feces ND ND
HO 5366 0426 2005 Sept 8 2 London Feces Diarrhea Unknown destination
HO 6018 0151 2006 Jan 6 3 Wexham Feces ND ND
HO 6316 0322 2006 Aug 3 4 Nottinghamshire Feces Diarrhea No recent travel
HO 6398 0463 2006 Sept 29 5 London Blood Fever and diarrhea India
HO 7078 0136 2007 Feb 16 6 Orpington Feces Diarrhea India
HO 7310 0210 2007 July 30 7 Wrexham Feces Diarrhea Unknown destination
HO 7468 0335 2007 Nov 16 8 Bedford Feces Enteritis India
HO 7474 0467 2007 Nov 21 9 West Sussex Feces Diarrhea ND
HO 7496 0137 2007 Dec 6 10 West Sussex Feces Diarrhea ND
HO 7512 0259 2007 Dec 18 11 Surrey Feces Diarrhea India
HO 8354 0857 2008 Aug 27 12 Kent ND Diarrhea Unknown destination
HO 8512 0713  2008 Dec 16  13 Spalding Food  NA NA
*ND, not determined; NA, not applicable. Europe. We also report that a producer of 16S rRNA meth-
yltransferase was isolated from food.
The overall isolation frequency of 16S rRNA methyl-
transferase–producing S. enterica is low (13/81,632 strains) 
in the United Kingdom, and these genes were absent in E. 
coli. However, spread of multidrug-resistant isolates that 
express 16S rRNA methyltransferases, ampliﬁ  ed by the as-
sociation of these genes with the ISEcp1 element, raises 
clinical concern that further spread is likely. Ongoing sur-
veillance of 16S rRNA methyltransferases in isolates found 
in food products and in humans and animals is crucial to 
delay the spread of resistance to these classes of antimicro-
bial agents.
Addendum
 While this manuscript was under revision, an S. en-
terica ser. Virchow isolate bearing the rmtC gene isolated 
from a child with a history of travel to India was reported 
in the United States (14). 
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